Advanced Search
Search
  
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire

Markets
Stocks
Sectors
Investing Tools
Overview
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
PHARMATHENE, Inc. (AM: PIP)
+0.00 (0.00%)
at
1.840
97,456 in Volume
Add to:
My Watchlist
Data as of 06:40 PM EST Feb 9,2010
Quote
Overview
Price and Volume
View Detailed Quote
chart
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
Today's Open 1.760
Bid (Size) 1.720 (2000)
Ask (Size) 1.840 (100)
Prev. Close 1.840
Today's Range 1.750 - 1.860
52wk Range 1.130 - 4.310
Shares Outstanding 28,435,598
Morningstar Profile
View Full Profile
PHARMATHENE, Inc.
A biodefense company, which is engaged in the development and commercialization of medical countermeasures against biological and chemical weapons in the United States.
Healthcare
Biotechnology
Exchange Traded AM
Market Cap 52.32M
Related Companies PRXI CHHHF POSGF AROAF
Featured News
Read More
PharmAthene Submits White Paper to BARDA for Advanced Development Funding for SparVax(TM) - Novel Recombinant Protective Antigen Anthrax Vaccine
Feb 01, 2010
from PRNewsWire News Releases
PharmAthene Updates Status of BARDA rPA Contract Discussions
Jan 05, 2010
from PRNewsWire News Releases
Featured News
Read More
PharmAthene Appoints Jeffrey W. Runge, M.D. to the Company's Board of Directors
Dec 21, 2009
from PRNewsWire News Releases
PharmAthene Announces Updated Time for Conference Call to Review BARDA rPA Decision
Dec 08, 2009
from PRNewsWire News Releases
BARDA Announces Modification to Development Approach for Recombinant Protective Antigen Anthrax Vaccines
Dec 07, 2009
from PRNewsWire News Releases
PharmAthene Presents Phase I Clinical Trial Results and New Therapeutic Animal Model Data for Protexia(R)
Dec 07, 2009
from PRNewsWire News Releases
More News
Read More
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Conference calls info supplied by OpenCompany
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA